• 1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Department of Oncology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. Department of Radiotherapy, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 4. Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 5. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
WANG Ziqiang, Email: wangzqzyh@163.com
Export PDF Favorites Scan Get Citation

Objective  To develop tailored treatment regimens for a patient with simultaneous liver metastasis of rectal cancer. Methods  Considering the patient's specific condition of different teatment stage, the specialists of oncology, imaging, gastroenterology, hepatic surgery, and radiotherapy conduct multidisciplinary consultation. Results  After hepatic metastatic tumor was resected, 4 cycles of XELOX chemotherapy combined with radiotherapy, tumor recurrence did not found in the liver. After resection of rectal cancer, the patient received 6 cycles of XELOX. The CEA and the thoracic, abdominal CT and pelvic MRI were reviewed 9 months after operation and no recurrence of the tumor was found. Conclusion  The MDT mechanism can provide individualized treatment for patients with advanced rectal cancer and benefit these patients.

Citation: ZHENG Bobo, HU Tao, DENG Xiangbing, QIU Meng, WANG xin, WU Hong, WU Bin, WANG Ziqiang. Clinical practice of MDT in simultaneous hepatic metastasis of rectal cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(3): 342-349. doi: 10.7507/1007-9424.201712103 Copy

  • Previous Article

    Laparoscopic splenectomy with behind splenic hilus tunnel-building technique
  • Next Article

    异鼠李素对胃癌细胞增殖及凋亡的影响